Get 40% Off
☕ Buy the dip? After losing 17%, Starbucks sees an estimated 20% upside. See the top Undervalued stocks!Unlock list

Insiders Buying Walgreens And 2 Other Stocks

Published 03/04/2024, 12:55
Updated 03/04/2024, 14:10
© Reuters.  Insiders Buying Walgreens And 2 Other Stocks

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Although U.S. stocks closed lower on Tuesday, there were a few notable insider trades.

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.

Walgreens Boots Alliance

The Trade: Walgreens Boots Alliance, Inc. (NASDAQ: WBA) EVP and Global CFO Manmohan Mahajan acquired a total of 6,000 shares an average price of $19.38. To acquire these shares, it cost around $116,280.

What’s Happening: On April 1, Morgan Stanley analyst Erin Wright maintained Walgreens with an Underweight and lowered the price target from $21 to $20.

What Walgreens Boots Alliance Does: Walgreens Boots Alliance is one of the largest retail pharmacy chains in the U.S., with over 8,500 locations. Nearly three quarters of Americans live within five miles of a Walgreens location.

Citi Trends

The Trade: Citi Trends, Inc. (NASDAQ: CTRN) 10% owner Pleasant Lake Partners LLC acquired a total of 18,000 shares at an average price of $27.10. To acquire these shares, it cost around $487,832.

What’s Happening: On March 19, Citi Trends reported worse-than-expected fourth-quarter financial results.

What Citi Trends Does: Citi Trends Inc is a retailer of urban fashion apparel and accessories in the United States.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Don’t forget to check out our premarket coverage here

PureCycle Technologies

The Trade: PureCycle Technologies, Inc. (NASDAQ: PCT) 10% owner Fernando Musa bought a total of 18,303 shares at an average price of $5.46. To acquire these shares, it cost around $99,934.

What’s Happening: On March 5, PureCycle Technologies, issued a corporate update for the fourth quarter and fiscal year ending Dec. 31, 2023.

What PureCycle Technologies Does: PureCycle Technologies Inc holds a license to commercialize the only patented solvent-based purification recycling technology, developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene (PP) into a virgin-like resin.

Check This Out: Acuity Brands, Cal-Maine Foods And 3 Stocks To Watch Heading Into Wednesday

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.